Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker.

Gut - 1 Oct 2020

Baselli Guido Alessandro, Dongiovanni Paola, Rametta Raffaela, Meroni Marica, Pelusi Serena, Maggioni Marco, Badiali Sara, Pingitore Piero, Maurotti Samantha, Montalcini Tiziana, Taliento Alice Emma, Prati Daniele, Rossi Giorgio, Fracanzani Anna Ludovica, Mancina Rosellina Margherita, Romeo Stefano, Valenti Luca

Abstract excerpt

OBJECTIVE: Efforts to manage non-alcoholic fatty liver disease (NAFLD) are limited by the incomplete understanding of the pathogenic mechanisms and the absence of accurate non-invasive biomarkers. The aim of this study was to identify novel NAFLD therapeutic targets andbiomarkers by conducting liver transcriptomic analysis in patients stratified by the presence of the PNPLA3 I148M genetic risk variant. DESIGN: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Discovery
Share to Interleukins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipase

Share to Non-alcoholic Fatty Liver Disease

Share to Obesity

Share to Severity of Illness Index

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 32001554
DOI: 10.1136/gutjnl-2019-319226
PMCID: PMC7497582

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker.PMID 32001554Read ↗

IL-32 is a stress-responsive node locked in a noncanonical NF-κB inflammatory loop during MASLD to HCC transitionSemantic proximity Read ↗

Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3I148M risk allele.Semantic proximity Read ↗

Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with Metabolically Dysfunction Associated Steatotic Liver DiseaseSemantic proximity Read ↗

IL32: The multifaceted and unconventional cytokine.Semantic proximity Read ↗

Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.Semantic proximity Read ↗

Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease.Semantic proximity Read ↗

TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease.Semantic proximity Read ↗

Relation of serum IL-32 levels and gene polymorphism rs45499297 with obesity in Mexican patients: a laboratory and in silico analysis.Semantic proximity Read ↗

IL-32 is a metabolic regulator promoting survival and proliferation of malignant plasma cellsSemantic proximity Read ↗

Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis.Semantic proximity Read ↗

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.